Efficacy and safety of utidelone for the treatment of patients with locally advanced or metastatic non-small-cell lung cancer who have failed standard second-line treatment: A phase 2 clinical trial (BG01-1801)
Cancer Pathogenesis and Therapy（2023）
Abstract
Image 1
MoreTranslated text
Key words
Utidelone,Locally advanced or metastatic non-small-cell lung cancer,Efficacy,Platinum- and taxane-refractory
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined